Association of C(-159)T polymorphism in the promoter of CD14 gene with coronary heart disease in Han population of Jiangsu province
Li L,Zhang K,Qiu F,Gu GY,Luo XY,Chen JH,Wang L,Xia YQ
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.43.046
2007-01-01
Abstract:AIM: To investigate the association between the C(-159)T polymorphism in the promoter of CD14 gene and coronary heart disease (CHD) in the Han population of Jiangsu province. METHODS: Between August 2003 and September 2005, 193 CHD patients were recruited from Nanjing Drumtower Hospital. They all had > 50% stenosis in at least one major coronary artery and were diagnosed by coronary angiography. Meanwhile 225 uncorrelated subjects who received routine health examination in the same hospital were taken as healthy control group. Using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method, the C(-159)T polymorphism in the promoter of CD14 gene were analyzed in CHD and control groups, the levels of serum lipid and soluble CD14 were also measured by biochemical and enzyme linked immunosorbent assay methods respectively. RESULTS: All the subjects completed the test and entered the result analysis.①The levels of serum lipids and soluble CD14: Compared with control group, CHD group had higher levels of serum total cholesterol, triglyceride, low-density lipoprotein cholesterol, and CD14, but the level of high-density lipoprotein cholesterol was lower in CHD group.②Genotype analysis: 3 genotypes were observed in the study: CC genotype, CT genotype, and TT genotype were 20.90%, 55.10%, 24.00% and 15.00%, 49.20%, 35.80% in control group and CHD group, respectively. And the control group was significantly higher than CHD group (χ2 =7.527, P < 0.05).③The genotype frequencies of C and T alleles were 48.40%, 51.60% and 39.40%, 60.60% in control group and CHD group, respectively. The difference between the two had a statistical significance (χ2 =6.858, P < 0.05).④No significant differences for the levels of serum lipids and soluble CD14 were found among TT, TC, and CC genotypes in CHD patients (P > 0.05). CONCLUSION: The C(-159)T polymorphism in the promoter of CD14 gene is associated with CHD in the Han population of Jiangsu province, and it might be a genetic predisposing predictor for CHD in the Han population.